Q&A with John Bothmer, Clinical Translation Medicine Fellow at Angelini Pharma To further explore the scientific, regulatory and operational complexity behind FirstinHuman trials , we spoke with John Bothmer, Clinical Translation Medicine Fellow within the Global Clinical Development & Clinical Operations department at Angelini Pharma , about the role these studies play in clinical development and the safeguards that support this transition from preclinical research to human investigation
Always work with a healthcare provider to develop a personalized treatment plan, especially if you suspect you have related conditions like MCAS or IBS
In both mouse models of autoimmune encephalomyelitis and human subjects, supplementation with zinc aspartate has been found to suppress the development of Th17 cells through the degradation of STAT-3, which may help alleviate the impact of Th17-driven autoimmune disorders [330, 331]
10.1186/1750-1326-6-8 41 BenjaminE
Furthermore, these findings align with the increased levels of iron and decreased autophagy observed in the brain during neurodegeneration [43]
Heart Issues: Increased risk of heart disease due to elevated homocysteine levels
